IGF2BP1 and hepatocellular carcinoma: Unlike most circular RNAs, circMAP3K4 was found to have coding potential, and IGF2BP1 recognizes circMAP3K4 N6-methyladenosine modification and promotes its translation, thereby protecting HCC cells from cisplatin exposure [20].